Martín-Sabroso C - Search Results

1

Insights into the effects of the endocannabinoid system in cancer: a review.

Fraguas-Sánchez AI, Martín-Sabroso C, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Br J Pharmacol. 2018 Jul;175(13):2566-2580. doi: 10.1111/bph.14331. Epub 2018 May 22. Br J Pharmacol. 2018. PMID: 29663308 Free PMC article. Review.

2

Current status of nanomedicine in the chemotherapy of breast cancer.

Fraguas-Sánchez AI, Martín-Sabroso C, Fernández-Carballido A, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Cancer Chemother Pharmacol. 2019 Oct;84(4):689-706. doi: 10.1007/s00280-019-03910-6. Epub 2019 Jul 31. Cancer Chemother Pharmacol. 2019. PMID: 31367789 Review.

3

CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer.

Fraguas-Sánchez AI, Fernández-Carballido A, Simancas-Herbada R, Martin-Sabroso C, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Among authors: martin sabroso c. Int J Pharm. 2020 Jan 25;574:118916. doi: 10.1016/j.ijpharm.2019.118916. Epub 2019 Dec 4. Int J Pharm. 2020. PMID: 31811927

4

PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment.

Fraguas-Sánchez AI, Torres-Suárez AI, Cohen M, Delie F, Bastida-Ruiz D, Yart L, Martin-Sabroso C, Fernández-Carballido A. Fraguas-Sánchez AI, et al. Among authors: martin sabroso c. Pharmaceutics. 2020 May 9;12(5):439. doi: 10.3390/pharmaceutics12050439. Pharmaceutics. 2020. PMID: 32397428 Free PMC article.

5

Stability characteristics of cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies.

Fraguas-Sánchez AI, Fernández-Carballido A, Martin-Sabroso C, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Among authors: martin sabroso c. J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Aug 1;1150:122188. doi: 10.1016/j.jchromb.2020.122188. Epub 2020 May 22. J Chromatogr B Analyt Technol Biomed Life Sci. 2020. PMID: 32506012

6

Timeline of Translational Formulation Technologies for Cancer Therapy: Successes, Failures, and Lessons Learned Therefrom.

Pérez-López A, Martín-Sabroso C, Torres-Suárez AI, Aparicio-Blanco J. Pérez-López A, et al. Among authors: martin sabroso c. Pharmaceutics. 2020 Oct 28;12(11):1028. doi: 10.3390/pharmaceutics12111028. Pharmaceutics. 2020. PMID: 33126622 Free PMC article. Review.

7

In vitro screening of nanomedicines through the blood brain barrier: A critical review.

Aparicio-Blanco J, Martín-Sabroso C, Torres-Suárez AI. Aparicio-Blanco J, et al. Biomaterials. 2016 Oct;103:229-255. doi: 10.1016/j.biomaterials.2016.06.051. Epub 2016 Jun 24. Biomaterials. 2016. PMID: 27392291 Review.

8

Objective: tumor. Strategies of drug targeting at the tumor mass level.

Martín Sabroso C, Torres-Suárez AI. Martín Sabroso C, et al. Clin Transl Oncol. 2014 Jan;16(1):1-10. doi: 10.1007/s12094-013-1075-4. Epub 2013 Jul 12. Clin Transl Oncol. 2014. PMID: 23846244 Review.

9

Validation protocol of analytical procedures for quantification of drugs in polymeric systems for parenteral administration: dexamethasone phosphate disodium microparticles.

Martín-Sabroso C, Tavares-Fernandes DF, Espada-García JI, Torres-Suárez AI. Martín-Sabroso C, et al. Int J Pharm. 2013 Dec 15;458(1):188-96. doi: 10.1016/j.ijpharm.2013.09.026. Epub 2013 Oct 9. Int J Pharm. 2013. PMID: 24120930

10

Critical attributes of formulation and of elaboration process of PLGA-protein microparticles.

Martín-Sabroso C, Fraguas-Sánchez AI, Aparicio-Blanco J, Cano-Abad MF, Torres-Suárez AI. Martín-Sabroso C, et al. Int J Pharm. 2015 Mar 1;480(1-2):27-36. doi: 10.1016/j.ijpharm.2015.01.008. Epub 2015 Jan 8. Int J Pharm. 2015. PMID: 25578370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results